• Email Preferences
    • Logout
    loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
    • Email Preferences
    • Logout
    loading
    Member
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 109
  3. 110
  4. 111
  5. 112
  6. 113
  7. …
  • Eli Lilly to supply COVID-19 antibody therapy to low-income countries

    13 October, 2020

    Antibody therapies to be made available in low-income countries...

    COVID-19

  • EU's potential COVID-19 vaccine doses top a billion with J&J deal

    13 October, 2020

    EU and J&J deal...

    COVID-19

  • Moderna to apply for EU's rolling approval for COVID-19 vaccine

    13 October, 2020

    Real-time reviews of vaccine candidates launched...

    COVID-19

  • WHO officials: the ethics and effectiveness of lockdown policies, natural herd immunity

    12 October, 2020

    WHO: Lockdowns not helpful to public health, but natural immunity is unethical..

    COVID-19

  • Infection in Young Adults as Harbinger of Hot Spots

    United States // 12 October, 2020

    Increasing rates in young adults precede outbreaks…

    COVID-19, General Articles

  • Potential New Use for Ranitidine Bismuth Citrate

    12 October, 2020

    Viral load decreased in animal study…

    General Articles, COVID-19

  • New Antibody Test Receives Emergency Use Authorisation

    United States // 12 October, 2020

    AdviseDx SARS-CoV-2 IgM test approved for emergency use…

    COVID-19

  • Study: COVID-19 Transmission Possible During Pregnancy

    Italy // 12 October, 2020

    Risk for transmission to foetus is low, but possible…

    COVID-19

  • South Korean company Celltrion receives approval for Phase 3 clinical trials of COVID-19 treatment

    South Korea // 12 October, 2020

    Antibody drug CT-P59

    COVID-19

  • Study: Brain Imaging Shows Neurological Effects of COVID-19

    France // 12 October, 2020

    Evidence compares brain imaging to neurological symptoms…

    COVID-19

  • Data suggests very low COVID-19 transmission risk in flight

    12 October, 2020

    Very few passengers infected onboard...

    COVID-19

  • Astrazeneca exempt from vaccine liability claims in most countries

    12 October, 2020

    Update on product liability claim of AstraZeneca...

    COVID-19

  • Britain prepares vaccination centres to roll out COVID-19 vaccine

    United Kingdom // 12 October, 2020

    Vaccination centres identified...

    COVID-19

  • UK launches clinical trial of BCG vaccine

    United Kingdom // 12 October, 2020

    Brace trial updates...

    COVID-19

  • New test that can detect coronavirus in five minutes being developed

    12 October, 2020

    Reviews on new test...

    COVID-19

  • Study: SARS-CoV-2 on surfaces

    Australia // 12 October, 2020

    A study conducted by the Australian CSIRO and published in Virology Journal demonstrated “[…]SARS-CoV-2 can remain infectious for significantly longer time periods than generally considered possible.”

    COVID-19

  • Study: Anti-malaria drug versus antiviral drug to treat COVID-19 in hamsters

    Belgium // 12 October, 2020

    Researchers at the KU Leuven Rega Institute gave SARS-CoV-2 infected hamsters either hydroxychloroquine (an anti-malarial drug) or favipiravir – a broad-spectrum antiviral drug used in in some countries to treat influenza.

    COVID-19

  • Study showing daily washing required for cloth masks

    Vietnam // 12 October, 2020

    A study published BMJ Open found that “[…} cloth masks must be washed daily to reduce the likelihood of contamination and transmission of viruses like SARS-CoV-2.”

    Seasonal Flu, COVID-19

  • Study: loss of smell and severity of COVID-19 illness

    Spain // 12 October, 2020

    A study published in Neurologic Sciences, looking at the impact of anosmia (loss of smell) on CoVID-19 prognosis, found “the presence of anosmia was an independent predictor of good outcome as reflected by a lower in-hospital mortality rate and less frequent ICU admission.

    COVID-19

  • Early hydroxychloroquine reduces admissions to intensive care

    Netherlands // 11 October, 2020

    An observational study carried out in the Netherlands...

    COVID-19

  1. …
  2. 109
  3. 110
  4. 111
  5. 112
  6. 113
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS